Alternative therapies for menopausal disorders
https://doi.org/10.21518/2079-701X-2019-13-131-136
Abstract
A woman’s life can be theoretically divided into certain periods: children’s, adolescent, reproductive and ageing. The latter is also called menopause. Everything related to ageing is usually associated with negative expectations and a pessimistic disposition. But if it is remembered, the word «climax» comes from the Greek language, meaning «staircase». Thus, menopause presents a culmination of a «female career». Each period is marked by its physiological characteristics, and menopause is no exception. The completion of the reproductive system functioning is often accompanied by the formation of a number of estrogen-deficient conditions. The latest modern insights, ranging from hormonal substances to alternative compounds, can effectively solve the problems of menopause.
About the Author
O. V. YakushevskayaRussian Federation
Oksana V. Yakushevskaya, Cand. of Sci. (Med.), Researcher, Gynaecological Endocrinology Department
4 Akademika Oparina Street, Moscow, 117997
References
1. Smetnik V.P. (ed.). Estrogens: from synthesis to clinical use. Moscow: Prakticheskaya Meditsina = Practical medicine. 2012. 174 p. (In Russ.) Available at: https://elibrary.ru/item.asp?id=23181995.
2. Sukhikh G.T., Smetnik V.P., Yureneva S.V., Ermakova E.I., Chernukha G.E., Yakushevskaya O.V. Menopause and climacteric condition in women. Clinical guidelines. 2016. 54 p. (In Russ.) Available at: http://naonob.ru/media/2018/07/07/1241338634/Menopauza_i_klimaktericheskoe_sostoyanie_u_zhenshhiny.pdf.
3. Kasyan V.N., Adamyan L.V. Pathophysiology of hot flashes with focus on neurohormonal regulation (a review). Problemy reproduktsii = Russian Journal of Human Reproduction. 2017;23(1):115-121. (In Russ.) doi: 10.17116/repro2017231115-121.
4. Mittelman-Smith M., Williams H., KrajewskiHall S.J., McMullen N.T., Rance N.E. Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. PNAS. 2012;109(48):19846-19851. doi: 10.1073/pnas.1211517109.
5. Biglia N., Cagnacci A., Gambacciani M., Lello S. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017;20(4):306312. doi: 10.1080/13697137.2017.1315089.
6. Thurston R., Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health across the Nation. Obstet Gynecol Clin North Am. 2011;(38):489–501. doi: 10.1016/j.ogc.2011.05.006.
7. Silveira J., Clapauch R., Souza M. Hot flashes: emerging cardiovascular risk factors in recent and late postmenopause and their association with higher blood pressure. Menopause. 2016;(23):846–55. doi: 10.1097/GME.0000000000000641.
8. Muka T., Oliver-Williams C. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2016;(11):e0157417. doi: 10.1371/journal.pone.0157417.
9. Thurston R., Johnson B.D., Pepine C., Shufelt C., Reis S., Kelsey S., Bittner V., Stanczyk F., Braunstein G., Berga S., Sopko G. Merz C.N.B. Early-onset menopausal vasomotor symptoms are associated with endothelial dysfunction: the National Heart Lung and Blood Institutesponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Journal of the American College of Cardiology. 2015;65(Suppl):Abstr 1512. doi: 10.1016/S0735-1097(15)61512-1. Available at: http://www.onlinejacc.org/content/65/10_Supplement/A1512.
10. Yakushevskaya O.V. The menopause – a new chapter giving women a lust for life. Meditsinsky Sovet = Medical Council. 2019;7:126132. (In Russ.) doi: 10.21518/2079-701X-20197-126-132.
11. Yureneva S.V., Ilyina L.M., Yakushevskaya O.V. Menopausal hormone therapy in postmenopausal women: the quality of life today and in the long term. Gynecology. 2016;18(1):24-29. (In Russ.) Available at: https://elibrary.ru/item.asp?id=25736837.
12. Kuznetsova I.V. Hormonal or non-hormonal medications in menopause? Medicinskij alfavit = Medical Alphabet. 2016;2(17):6-12. (In Russ.) Available at: https://elibrary.ru/item.asp?id=28394553.
13. Yureneva S., Moisseyev S. Evidence-based nonhormonal treatment of menopausal vasomotor symptoms. Klinicheskaya farmakologiya i terapiya = Clinical pharmacology and therapy. 2010;19(2):69-74. (In Russ.) Available at: https://elibrary.ru/item.asp?id=23181995.
14. Maki P.M. Verbal memory and menopause. Maturitas. 2015;(82):288-290. doi: 10.1016/j.maturitas.2015.07.023.
15. Ghazanfarpour M., Sadeghi R. Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and metaanalysis. Avicenna Journal of Phytomedicine. 2015;5(6):498-511. doi: 10.22038/ajp.2015.4468.
16. Luis A., Domingues F. & Pereira L. Effects of red clover on perimenopausal and postmenopausal women’s blood lipid profile: A metaanalysis. Climacteric. 2018;21(5):446-453. doi: 10.1080/13697137.2018.1501673.
17. Balan V.E., Rafalian I.V., Levkovich E.A., Orlova S.A., Grigor’eva D.V. Specific features of longterm use of phytoestrogens to treat patients with climacteric syndrome. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2013;13(5):58-62. (In Russ.) Available at: https://www.mediasphera.ru/issues/rossijskij-vestnik-akushera-ginekologa/2013/5/031726-61222013513.
Review
For citations:
Yakushevskaya OV. Alternative therapies for menopausal disorders. Meditsinskiy sovet = Medical Council. 2019;(13):131-136. (In Russ.) https://doi.org/10.21518/2079-701X-2019-13-131-136